Fig. 1: The double-key model for using predictive genetic test results in insurance underwriting in Singapore* (adapted from Life Insurance Association of Singapore54, generated using Sketchbook and PowerPoint).
From: Addressing genetic discrimination for stronger legal protections and enhanced public awareness

*At the time of revising this manuscript, the Moratorium was updated. The revised moratorium protects results of any genetic tests (predictive or diagnostic) conducted under the national Familial Hypercholesterolaemia (FH) genetic testing programme from being used in insurance underwriting55.